Market Tracker

07/23 6:05pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

55.86
Data as of Jul 23
 +0.60 / +1.09%
Today’s Change
43.92
Today|||52-Week Range
112.57
-13.13%
Year-to-Date

Today’s Trading

Previous close55.26
Today’s open55.83
Day’s range55.01 - 57.14
Volume359,153
Average volume (3 months)909,941
Market cap$4.2B
Dividend yield--
Data as of 4:00pm ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-263.45%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book13.03

Competitors

 Today’s
change
Today’s
% change
IDIXIdenix Pharmaceutica...+0.01+0.04%
ISISIsis Pharmaceuticals...+1.46+4.88%
CBSTCubist Pharmaceutica...-3.12-4.75%
PRXLPAREXEL Internationa...+0.28+0.52%
Data as of 4:00pm ET, 07/23/2014

Financials

Next reporting dateAugust 4, 2014
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts